Floatz logo

Therapeutic Asset Ratings

157 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Benadryl
Primary Progressive Multiple Sclerosis
Hoffmann-La RocheP3B (62)
Desloratadine
Primary Progressive Multiple Sclerosis
Hoffmann-La RocheP3B (62)
DEXAMETHASONE
Primary Progressive Multiple Sclerosis
Hoffmann-La RocheP3B (62)
Fenebrutinib
Relapsing Multiple Sclerosis
Hoffmann-La RocheP3B (62)
RANITIDINE
Multiple Myeloma
Hoffmann-La RocheP3B (62)
Atezolizumab
Estrogen Receptor-positive
Hoffmann-La RocheP2B (62)
Atezolizumab
Solid Tumor
Hoffmann-La RocheP2/3B (62)
FACTOR VIII (HUMAN)
Hemophilia A
Hoffmann-La RocheP3B (61)
Tiragolumab
Non-small Cell Lung Cancer
Hoffmann-La RocheP3B (61)
CIS-DIAMMINEDICHLOROPLATINUM II
Head and Neck Neoplasms
Hoffmann-La RocheP3B (60)
Desloratadine
Relapsing Multiple Sclerosis
Hoffmann-La RocheP3B (60)
Fenebrutinib
Multiple Sclerosis, Primary Progressive
Hoffmann-La RocheP3B (60)
Tocilizumab
Diffuse Large B-cell Lymphoma
Hoffmann-La RocheP3B (60)
Benadryl
Relapsing Multiple Sclerosis
Hoffmann-La RocheP3B (59)
DEXAMETHASONE
Relapsing Multiple Sclerosis
Hoffmann-La RocheP3B (59)
nxt007
Hemophilia A
Hoffmann-La RocheP3B (59)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
B-cell Lymphoma
Hoffmann-La RocheP3B (58)
Tiragolumab
Carcinoma, Hepatocellular
Hoffmann-La RocheP3B (58)
ro7247669
Melanoma
Hoffmann-La RocheP2B (58)
Tocilizumab
B-cell Non-Hodgkin Lymphoma
Hoffmann-La RocheP1/2B (58)
PITAVASTATIN
Obesity
Hoffmann-La RocheP3B (57)
Tocilizumab
Follicular Lymphoma
Hoffmann-La RocheP3B (57)
Tocilizumab
Lymphoma
Hoffmann-La RocheP3B (57)
Atezolizumab
PD-L1-selected Solid Tumors
Hoffmann-La RocheP2B (57)
Tiragolumab
Metastatic Renal Cell Carcinoma
Hoffmann-La RocheP2B (57)
Showing 26 to 50 of 157 assets
PreviousPage 2 of 7Next